How do early-life exposures shape the infant skin microbiome and atopic dermatitis risk? New cohort data reveal key ...
Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and ...
Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.
Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...
A study published in Nutrition Reviews in November 2025 found evidence linking oral probiotics and synbiotics to improvements in atopic dermatitis (AD) symptoms. However, research for other skin ...
Sanofi's amlitelimab confirms its potential in atopic dermatitisIn the SHORE phase 3 study, amlitelimab in combination with topical therapies met ...
If you’re a person of color, finding the right treatment for atopic dermatitis, a common form of eczema, can be challenging. Even though the disease is more prevalent in Black Americans than white ...
Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with ...
NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling ...
But when you add being Black to the equation — and the racism and other forms of bias that come with it — those negative feelings can intensify. It’s common for Black people with atopic dermatitis to ...
The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results